Reply to the letter "About sorafenib in castration-resistant prostate cancer" by G. Colloca, F. Checcaglini and A. Venturino.
作者信息
Chi K N, Seymour L
机构信息
Department of Clinical Trials, University of British Columbia, Vancouver.
National Cancer Institute of Canada-Clinical Trials Group, Queen's University, Kingston, Canada.
出版信息
Ann Oncol. 2008 Oct;19(10):1813-1814. doi: 10.1093/annonc/mdn549. Epub 2019 Dec 3.
PMID:32559998
Abstract
摘要
Zotero 插件